PIK3CA Mutation is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients.

Cancer Res Treat · 2023 · PMC10101795 · PMID 36097803

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

marginally significantp=0.090so close (0.05 < p ≤ 0.1)

Altogether, 25% of patients with PIK3CA m and 66.7% with PIK3CA w were reported to have achieved pCR, and the difference between these two groups was marginally significant (p=0.090, chi-square test).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.